TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NKTX

Nkarta Inc

Healthcare · Biotechnology

2.60$ +0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Nkarta Inc (NKTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 338 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NKTX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
406 379 577 554 532 501 471 448 427 404 372 338
281 253 443 332 290 273 272 297 289 283 236 188
38 31 250 120 57 28 53 53 60 40 27 25
276 248 437 325 283 267 266 290 282 276 230 183
– 0.2 1.3 2.1 2.5 0.2 2.4 2.2 2.1 2.0 1.7 –
109 106 103 101 101 93 92 91 89 92 86 90
26 23 22 21 22 19 19 19 19 22 18 24
6.1 6.1 6.1 5.5 6.8 6.1 6.0 6.9 6.4 6.9 7.1 7.3
4.3 3.7 3.2 3.8 1.9 0.6 1.5 1.5 1.4 2.1 1.6 3.8
297 273 474 453 431 408 379 358 338 312 286 248
-408 -435 -465 -490 -518 -544 -576 -599 -621 -648 -676 -717
49 49 51 73 74 74 74 74 74 74 74 74

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?